MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis JS Vermaat, SF Somers, LC de Wreede, W Kraan, RAL de Groen, ... Haematologica 105 (2), 424, 2020 | 14 | 2020 |
MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications RAL de Groen, AMR Schrader, MJ Kersten, ST Pals, JSP Vermaat haematologica 104 (12), 2337, 2019 | 13 | 2019 |
IGLV3-21* 01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling PC Maity, M Bilal, MT Koning, M Young, CAM van Bergen, V Renna, ... Proceedings of the National Academy of Sciences 117 (8), 4320-4327, 2020 | 11 | 2020 |
Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing W Arindrarto, DM Borràs, RAL de Groen, RR van den Berg, IJ Locher, ... Leukemia, 1-15, 2020 | 7 | 2020 |
High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites S Elfrink, CM de Winde, M van den Brand, M Berendsen, MGM Roemer, ... blood 134 (12), 946-950, 2019 | 2 | 2019 |
High-Throughput BCR Sequencing and Single-Cell Transcriptomics Reveal Distinct Transcriptional Profiles Associated with Subclonal Evolution of Follicular Lymphoma CAM van Bergen, MT Koning, E Quinten, A Mykowiecka, J Sepulveda, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype RAL De Groen, R Van Eijk, T van Wezel, R Raghoo, AR Schrader, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
PF509 MOLECULAR ANALYSIS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA LEG TYPE AT DIAGNOSIS AND RELAPSE–IMPLICATIONS FOR TARGETED THERAPIES AMR Schrader, RAL de Groen, R Willemze, PM Jansen, KD Quint, ... HemaSphere 3 (S1), 207-208, 2019 | | 2019 |
PF519 MOLECULAR PROFILING OF PRIMARY BONE LYMPHOMA'S REVEALS FREQUENT MUTATIONS IN EZH2 AND OTHER EPIGENETIC GENES: IMPLICATIONS FOR TARGETED TREATMENT MS Ibramoglu, RA de Groen, R van Eijk, T van Wezel, R Raghoo, ... HemaSphere 3 (S1), 212, 2019 | | 2019 |
Molecular Profiling of Primary and Secondary Bone Lymphomas: Frequent Mutations in EZH2 and other Epigenetic Genes Implicate Germinal-Center B-cell Origin S Somers, R de Groen, R van Eijk, T van Wezel, E de Winter, H Veelken, ... LABORATORY INVESTIGATION 99, 2019 | | 2019 |
Molecular analysis of primary cutaneous diffuse large B-cell lymphoma, leg type at diagnosis and relapse AMR Schrader, RAL de Groen, R Willemze, PM Jansen, KD Quint, ... European Journal of Cancer 119, S8-S9, 2019 | | 2019 |